Inflammatory effects of platelet activating factor (PAF) in equine skin
- 1 May 1992
- journal article
- Published by Wiley in Equine Veterinary Journal
- Vol. 24 (3) , 208-214
- https://doi.org/10.1111/j.2042-3306.1992.tb02817.x
Abstract
Intradermal administration of PAF (0.001 −1 μg/site), but not lyso‐PAF (10 μg/site), in the horse caused an increase in cutaneous vascular permeability which was maximal by 32 min. Responses to PAF and histamine were reduced by coadministration of the histamine 1 receptor antagonist chlorpheniramine, although only the inhibition of histamine‐induced responses was dose‐related and statistically significant. The cyclo‐oxygenase inhibitor indomethacin was without effect on PAF‐induced increases in vascular permeability. These findings suggest that the actions of PAF on equine skin microvasculature may be partly due to histamine release but not to prostanoid formation. Coadministration of prostaglandin (PG) E2 enhanced the oedematous responses to both PAF and histamine, although PGE2 failed to exert direct permeability‐increasing activity. In addition, and in contrast to PAF and histamine, PGE2 increased cutaneous blood flow and skin surface temperature. PAF, but not lyso‐PAF, also caused neutrophil infiltration into the skin which was maximal at 2 h. No significant effects on eosinophil or mononuclear cell numbers were apparent up to 24 h after injection of PAF. These results are consistent with the concept that PAF may be a mediator of inflammatory disorders of the skin in the horse.Keywords
This publication has 21 references indexed in Scilit:
- Assessment of histamine, bradykinin, prostaglandins E1 and E2 and carrageenin as vascular permeability agents in the horseJournal of Veterinary Pharmacology and Therapeutics, 1991
- Calcium‐ionophore‐induced formation of platelet‐activating factor and leukotrienes by horse eosinophils: a comparative studyEuropean Journal of Biochemistry, 1990
- Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjectsJournal of Allergy and Clinical Immunology, 1988
- Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in ratsInflammation Research, 1988
- Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in manJournal of Allergy and Clinical Immunology, 1988
- Skin eosinophilia in atopic patientsJournal of Allergy and Clinical Immunology, 1988
- Dermal reactivity to histamine, serotonin and bradykinin in relation to allergic skin reactions of the horseJournal of Veterinary Pharmacology and Therapeutics, 1986
- Association of Platelet-Activating Factor with Primary Acquired Cold UrticariaNew England Journal of Medicine, 1985
- Inflammatory characteristics of platelet activating factor (PAF-acether) in human skinBritish Journal of Dermatology, 1984
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972